Streetbeat News

Products Services

VLVLY

XPEV

XPENG and Volkswagen Group have signed a master agreement to jointly develop advanced E/E Architecture for the Chinese market. The first vehicle with this architecture will start production in about 24 months, and both companies are exploring further collaboration opportunities.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:47 am

MESO

Mesoblast has started enrolling patients in a Phase 3 trial for its drug candidate Rexlemestrocel-L, aimed at treating chronic low back pain.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:38 am

RTX

RTX's Pratt & Whitney Canada and Collins Aerospace have been chosen by Airbus Helicopters to develop a hybrid-electric propulsion system for the PioneerLab technology demonstrator, aiming for a 30% improvement in fuel efficiency. Test flights are expected to begin in 2027.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:28 am

HIVE

HIVE Digital is set to build a 100 MW data center in Paraguay, aiming to achieve a 12 EH/S hashrate and double its revenue.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:25 am

BA

Boeing projects a need for 44,000 new airplanes by 2043, driven by a 4.7% annual passenger growth rate. The company expects a 3% increase in airplane deliveries over the next 20 years, with emerging markets and single-aisle market demand being key growth drivers.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:22 am

JNJ

Addex's partner Janssen has decided to discontinue the development of ADX71149 for epilepsy treatment after a Phase 2 study failed to meet its primary endpoint. The study showed that ADX71149 did not significantly improve seizure control in patients with focal onset seizures.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:12 am

TSLA

Tesla Inc (NASDAQ:TSLA) aims to start selling its Cybertruck in Canada this year, with pre-orders available for $150. Transport Canada has granted approval for the vehicle's steel-by-wire system, marking an important milestone despite additional regulatory requirements.

Portfolio Pulse from Anan Ashraf

July 22, 2024 | 6:04 am

VALN

Valneva has secured up to $41.3 million from CEPI and the European Union to expand access to its chikungunya vaccine, IXCHIQ®. The funding will support clinical trials in vulnerable groups and technology transfer to an additional manufacturer for supply to Asian LMICs. IXCHIQ® is already approved for adults in the U.S., Canada, and Europe.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 6:02 am

AAPL

SONY

Apple Inc. (NASDAQ:AAPL) has extended a three-month free trial of its Apple TV+ service to owners of Sony Group Corp.’s (NYSE:SONY) PlayStation 4 and 5 models. This offer is valid until September 22, 2024, and is an upgrade from Apple's usual one-week trial period for new users.

Portfolio Pulse from Ananya Gairola

July 22, 2024 | 3:59 am

ETH

SOL

The U.S. political landscape saw a major shift as Joe Biden dropped out of the 2024 presidential race, causing volatility in Trump-themed cryptocurrencies. MAGA Coin plunged 8%, while a Solana-based Donald Trump memecoin surged 53%.

Portfolio Pulse from Aniket Verma

July 22, 2024 | 3:47 am